Brief: Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results

Aceragen

14/11/2022 21:31

Nov 14 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * IDERA PHARMACEUTICALS INC - QTRLY  NET LOSS PER BASIC
$0.06
    * IDERA PHARMACEUTICALS INC - EXPECTS TO INITIATE ADVANCE
CLINICAL
STUDY FOR ACG-801 IN FARBER DISEASE IN 2H 2023 WITH DATA
EXPECTED IN Q1 2024
    * IDERA PHARMACEUTICALS INC - ADVANCE STUDY IS ON TRACK FOR
INITIATION IN SECOND HALF OF 2023

Source text for Eikon:  ID:nGNXW8Z1v 
Further company coverage:  IDRA.O 
 ((Reuters.Briefs@thomsonreuters.com;))